{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T03:44:29Z","timestamp":1772163869330,"version":"3.50.1"},"reference-count":35,"publisher":"BMJ","issue":"2","license":[{"start":{"date-parts":[[2020,7,16]],"date-time":"2020-07-16T00:00:00Z","timestamp":1594857600000},"content-version":"unspecified","delay-in-days":15,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Open Heart"],"accepted":{"date-parts":[[2020,5,1]]},"published-print":{"date-parts":[[2020,7]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The ADP-scavenging enzyme creatine kinase (CK) is reported to reduce ADP-dependent platelet activation. Therefore, we studied whether highly elevated CK after ST-elevation myocardial infarction (STEMI) is associated with bleeding.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Data of the Thrombolysis in Myocardial Infarction Study Group phase II trial on the efficacy of angioplasty, following intravenous recombinant tissue-type plasminogen activator (rt-PA), are used to assess whether peak plasma CK (CKmax) is independently associated with adjudicated fatal or non-fatal bleeding (primary) and combined bleeding\/all-cause mortality (secondary) in multivariable binomial logistic regression analysis, adjusting for baseline and treatment allocation covariates.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The included patients (n=3339, 82% men, 88% white, mean age 57 years, SE 0.2) had a history of angina pectoris (55%), hypertension (38%) and\/or diabetes mellitus (13%). CKmax ranged from 16 to 55 890\u2009IU\/L (mean 2389\u2009IU\/L, SE 41), reached within 8\u2009hours in 51% of the patients (93% within 24\u2009hours). Adjudicated fatal\/non-fatal bleeding occurred in 30% of the patients (respectively 26% in the low vs 34% in the high CK tertile), and bleeding\/all-cause mortality in 35% (29% in the low vs 40% in the high CK tertile). In multivariable regression analysis, the adjusted OR for fatal\/non-fatal bleeding (vs not bleeding and survival) was 2.6 (95% CI 1.8 to 3.7)\/log CKmax increase, and 3.1 (2.2 to 4.4) for bleeding\/all-cause mortality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Highly elevated plasma CK after myocardial infarction might be an independent predictor of bleeding and haemorrhagic death. This biologically plausible association warrants further prospective study of the potential role of extracellular CK in ADP-dependent platelet activation and bleeding.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/openhrt-2020-001261","type":"journal-article","created":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T02:27:09Z","timestamp":1594952829000},"page":"e001261","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":5,"title":["Creatine kinase is associated with bleeding after myocardial infarction"],"prefix":"10.1136","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7434-0038","authenticated-orcid":false,"given":"Lizzy Maritza","family":"Brewster","sequence":"first","affiliation":[{"name":"CK Science Foundation, Amsterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jim","family":"Fernand","sequence":"additional","affiliation":[{"name":"Clinic for Health and Individual Medicine, Utrecht, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2020,7,16]]},"reference":[{"key":"2025081612013910000_7.2.e001261.1","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/eurheartj\/ehx393","article-title":"2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the task force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of cardiology (ESC)","volume":"39","author":"Ibanez","year":"2018","journal-title":"Eur Heart J"},{"key":"2025081612013910000_7.2.e001261.2","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000404"},{"key":"2025081612013910000_7.2.e001261.3","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0b013e3182742cf6"},{"key":"2025081612013910000_7.2.e001261.4","doi-asserted-by":"publisher","DOI":"10.1161\/STR.0000000000000158"},{"key":"2025081612013910000_7.2.e001261.5","doi-asserted-by":"publisher","DOI":"10.1016\/S0195-668X(03)00485-8"},{"key":"2025081612013910000_7.2.e001261.6","doi-asserted-by":"crossref","first-page":"292","DOI":"10.21037\/atm.2018.07.15","article-title":"Creatine kinase, energy reserve, and hypertension: from bench to bedside","volume":"6","author":"Brewster","year":"2018","journal-title":"Ann Transl Med"},{"key":"2025081612013910000_7.2.e001261.7","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.114.303412"},{"key":"2025081612013910000_7.2.e001261.8","doi-asserted-by":"publisher","DOI":"10.1055\/s-0035-1564835"},{"key":"2025081612013910000_7.2.e001261.9","doi-asserted-by":"crossref","first-page":"295","DOI":"10.4070\/kcj.2012.42.5.295","article-title":"Mechanisms of platelet activation and integrin \u03b1II\u03b23","volume":"42","author":"Joo","year":"2012","journal-title":"Korean Circ J"},{"key":"2025081612013910000_7.2.e001261.10","doi-asserted-by":"crossref","first-page":"915","DOI":"10.3390\/ph6080915","article-title":"Targeting platelet thrombin receptor signaling to prevent thrombosis","volume":"6","author":"Wallace","year":"2013","journal-title":"Pharmaceuticals"},{"key":"2025081612013910000_7.2.e001261.11","doi-asserted-by":"crossref","first-page":"e618","DOI":"10.1161\/CIR.0000000000000617","article-title":"Fourth universal definition of myocardial infarction (2018)","volume":"138","author":"Thygesen","year":"2018","journal-title":"Circulation"},{"key":"2025081612013910000_7.2.e001261.12","unstructured":"The TIMI study group . TIMI trials 1984. 11th edn, 2017. www.timi.org"},{"key":"2025081612013910000_7.2.e001261.13","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1988.03410190097031"},{"key":"2025081612013910000_7.2.e001261.14","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.81.5.1457"},{"key":"2025081612013910000_7.2.e001261.15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198903093201002"},{"key":"2025081612013910000_7.2.e001261.16","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.83.2.422"},{"key":"2025081612013910000_7.2.e001261.17","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-115-4-256"},{"key":"2025081612013910000_7.2.e001261.18","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(87)80296-6"},{"key":"2025081612013910000_7.2.e001261.19","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0258(19980730)17:14<1623::AID-SIM871>3.0.CO;2-S"},{"key":"2025081612013910000_7.2.e001261.20","doi-asserted-by":"publisher","DOI":"10.1080\/00031305.2019.1583913"},{"key":"2025081612013910000_7.2.e001261.21","doi-asserted-by":"publisher","DOI":"10.1067\/mlc.2002.126719"},{"key":"2025081612013910000_7.2.e001261.22","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1039\/b909873a","article-title":"The dual nature of extracellular ATP as a concentration-dependent platelet P2X1 agonist and antagonist","volume":"1","author":"Karunarathne","year":"2009","journal-title":"Integr Biol"},{"key":"2025081612013910000_7.2.e001261.23","doi-asserted-by":"crossref","DOI":"10.1007\/s11302-020-09707-0","article-title":"Extracellular creatine kinase may modulate purinergic signalling","author":"Brewster","year":"2020","journal-title":"Purinergic Signal"},{"key":"2025081612013910000_7.2.e001261.24","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.116.309726"},{"key":"2025081612013910000_7.2.e001261.25","first-page":"1513","article-title":"Changes in platelet functions, coagulation and fibrinolysis in uncomplicated cases of acute myocardial infarction","volume":"42","author":"Knudsen","year":"1980","journal-title":"Thromb Haemost"},{"key":"2025081612013910000_7.2.e001261.26","doi-asserted-by":"publisher","DOI":"10.1177\/1457496914531927"},{"key":"2025081612013910000_7.2.e001261.27","doi-asserted-by":"publisher","DOI":"10.1373\/49.8.1331"},{"key":"2025081612013910000_7.2.e001261.28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0032471"},{"key":"2025081612013910000_7.2.e001261.29","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2007.06.008"},{"key":"2025081612013910000_7.2.e001261.30","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2010.07.028"},{"key":"2025081612013910000_7.2.e001261.31","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2008.08.031"},{"key":"2025081612013910000_7.2.e001261.32","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1001\/jamainternmed.2014.5398","article-title":"Risk of bleeding with dabigatran in atrial fibrillation","volume":"175","author":"Hernandez","year":"2015","journal-title":"JAMA Intern Med"},{"key":"2025081612013910000_7.2.e001261.33","doi-asserted-by":"publisher","DOI":"10.1136\/heart.88.1.1"},{"key":"2025081612013910000_7.2.e001261.34","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2005.12.003"},{"key":"2025081612013910000_7.2.e001261.35","first-page":"95","article-title":"Routinely available biomarkers as long-term predictors of developing systolic dysfunction in completely revascularized patients with acute ST elevation myocardial infarction","volume":"58","author":"Zeljkovi\u0107","year":"2019","journal-title":"Acta Clin Croat"}],"container-title":["Open Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/openhrt-2020-001261","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,16]],"date-time":"2025-08-16T19:01:48Z","timestamp":1755370908000},"score":1,"resource":{"primary":{"URL":"https:\/\/openheart.bmj.com\/lookup\/doi\/10.1136\/openhrt-2020-001261"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":35,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2020,7,16]]},"published-print":{"date-parts":[[2020,7]]}},"alternative-id":["10.1136\/openhrt-2020-001261"],"URL":"https:\/\/doi.org\/10.1136\/openhrt-2020-001261","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/19012039","asserted-by":"object"}]},"ISSN":["2053-3624"],"issn-type":[{"value":"2053-3624","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7]]}}}